Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial DNA analysis: polymorphisms and pathogenicity.

P F Chinnery1, N Howell, R M Andrews

  • 1Department of Neurology, The University of Newcastle upon Tyne, UK.

Journal of Medical Genetics
|July 29, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review of cognitive deficits in adult mitochondrial disease.

European journal of neurology·2019
Same author

Design and baseline characteristics of the Biomarkers Of Risk In Colorectal Cancer (BORICC) Follow-Up study: A 12+ years follow-up.

Nutrition and health·2019
Same author

Effects of obesity and weight loss on mitochondrial structure and function and implications for colorectal cancer risk.

The Proceedings of the Nutrition Society·2019
Same author

A case-comparison study of pregnant women with mitochondrial disease - what to expect?

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

Mitochondrial respiratory chain function and content are preserved in the skeletal muscle of active very old men and women.

Experimental gerontology·2018
Same author

Mitochondrial disease in pregnancy: a systematic review.

Obstetric medicine·2016
Same journal

Longest surviving patient with a homozygous splice-altering <i>EGFR</i> pathogenic variant presenting with skin autoinflammation and a Bartter-like salt-losing tubulopathy.

Journal of medical genetics·2026
Same journal

Functional characterisation and pathological significance of variants of <i>MEF2C</i> promoter in tetralogy of Fallot.

Journal of medical genetics·2026
Same journal

Identification of biallelic loss-of-function <i>PREP</i> variants in three individuals with syndromic intellectual disability.

Journal of medical genetics·2026
Same journal

Inherited retinal disease genes with dual inheritance patterns: insights from the IRD-PT registry.

Journal of medical genetics·2026
Same journal

Interpreting <i>TP53</i> variants: somatic mosaicism and <i>ERCC6L2</i>-driven clonal evolution.

Journal of medical genetics·2026
Same journal

Review of estimates of birth incidence and population prevalence over time and between countries of the rare neurodevelopmental condition Prader-Willi syndrome.

Journal of medical genetics·2026
See all related articles

Investigating mitochondrial DNA (mtDNA) diseases is challenging when known defects are absent or symptoms are complex. This study outlines methods to identify and confirm pathogenic mtDNA mutations in genetic and multifactorial disorders.

Area of Science:

  • Mitochondrial genetics
  • Human genetics
  • Molecular biology

Background:

  • Mitochondrial DNA (mtDNA) diseases present diagnostic challenges, especially with atypical phenotypes or unknown mutations.
  • Complexity arises when clinical manifestations do not align with common mitochondrial disorders or when no known mtDNA defect is identified.

Purpose of the Study:

  • To describe the difficulties encountered in identifying pathogenic mtDNA mutations.
  • To present approaches for confirming or refuting the pathogenic role of suspected mtDNA mutations.
  • To address challenges in both single-gene and multifactorial mitochondrial disorders.

Main Methods:

  • Review of diagnostic challenges in mtDNA disease.
  • Description of methodologies for mutation identification.

Related Experiment Videos

  • Strategies for variant pathogenicity assessment.

    • Main Results:

    • Identification of pathogenic mtDNA mutations can be complex, requiring careful analysis.
    • Diagnostic approaches need to account for both known and novel mutations.
    • Confirmation of pathogenicity is crucial for accurate diagnosis and treatment.

    Conclusions:

    • Accurate diagnosis of mtDNA disease requires robust methods to identify and validate pathogenic mutations.
    • Addressing diagnostic complexities is essential for patients with unexplained or complex mitochondrial disorders.
    • Further development of analytical strategies is needed for challenging cases.